Prof. Dr. Lars Nitschke

Professur für Genetik

CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation (2025) Felixberger PT, Andrieux G, Maul-Pavicic A, Goldacker S, Harder I, Gutenberger S, Landry JJ, et al. Journal article Sialic acids on T cells are crucial for their maintenance and survival (2024) Schmidt M, Linder A, Korn M, Schellenberg N, Meyer SJ, Nimmerjahn F, Werner A, et al. Journal article IgG sialylation occurs in B cells pre antibody secretion (2024) Werner A, Hanić M, Zaitseva OO, Lauc G, Lux A, Nitschke L, Nimmerjahn F Journal article The role of Siglec-G on B cells in autoimmune disease and leukemia (2023) Röder B, Nitschke L Journal article The inhibitory receptor Siglec-G controls the severity of chronic lymphocytic leukemia (2023) Röder B, Fahnenstiel H, Schäfer S, Budeus B, Dampmann M, Eichhorn M, Angermüller S, et al. Journal article Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus (2023) Korn M, Steffensen M, Brandl C, Royzman D, Daniel C, Winkler T, Nitschke L Journal article Sialic acids on B cells are crucial for their survival and provide protection against apoptosis (2022) Linder A, Schmidt M, Hitschfel J, Schneider P, Abeln M, Gerardy-Schahn R, Muenster-Kuehnel A, Nitschke L Conference contribution Siglec-G controls the severity of chronic lymphocytic leukemia (2022) Röder B, Fahnenstiel H, Seifert M, Schäfer S, Winkler T, Nitschke L Conference contribution Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics (2022) Prescher H, Schweizer A, Frank M, Kuhfeldt E, Ring J, Nitschke L Journal article B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia (2022) Schmid VK, Khadour A, Ahmed N, Brandl C, Nitschke L, Rajewsky K, Jumaa H, Hobeika E Journal article